NIH-funded research R01 grant

Engage: Telehealth psychosocial support to reduce symptom interference in advanced cancer

Official title: Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients with Advanced Cancer

Funded at Duke University · NIH-11369638 · Data updated 2026-11-12

A proven, doctor-guided telehealth program helps people with advanced cancer cope with pain, fatigue, and distress so these symptoms interfere less with daily life.

More Randomized Controlled Trial research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startAugust 1, 2024
Project endJuly 31, 2029
Funding year2026
Award (this year)$1,664,531
NIH project number4R01CA291768-03
Project IDNIH-11369638 on NIH RePORTER

Who could benefit from this research

Could help

Adults with advanced cancer who experience pain, fatigue, and distress that significantly affect daily functioning.

Less likely to help

Patients with conditions or circumstances that prevent participation in telehealth sessions or who have symptoms not primarily related to cancer.

What this research studies

This project tests a remote psychosocial program called ENGAGE, designed for people living with advanced cancer. It combines traditional CBT skills with Acceptance and Commitment Therapy to help patients manage symptoms and live more in line with their values. Participants receive telehealth sessions focusing on coping strategies, mindfulness, and activity planning to lessen how symptoms disrupt daily life. If successful, the program could be integrated into standard care to improve quality of life for patients at home. The study builds on earlier small trials that showed the approach is feasible and acceptable.

Why it matters

Potential benefit: If effective, patients could experience less symptom interference and better overall quality of life through accessible telehealth support.

How similar studies have gone: Prior small trials suggest ENGAGE is feasible and acceptable and may improve patient-reported outcomes, warranting a larger, well-powered test.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Winger, Joseph Giles — Duke University
  • Study coordinator: Winger, Joseph Giles

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.